10 Best Emerging Technology Stocks to Buy Now

2. GeneDx Holdings Corp. (NASDAQ:WGS)

Focus Area: Genetic testing services

Potential Upside: 12%

Number of Hedge Fund Holders: 32

GeneDx Holdings Corp. (NASDAQ:WGS) is a genomics and precision medicine company specializing in genetic testing, next-generation sequencing (NGS), and AI-powered diagnostics.

The company leverages next-generation sequencing (NGS) and AI-driven genomic analysis to improve early disease detection and advance personalized medicine. Its focus is on identifying rare genetic diseases, pediatric disorders, and hereditary conditions, enabling early diagnosis, more informed treatment decisions, and better patient outcomes. By utilizing whole genome and exome sequencing, GeneDx Holdings Corp. (NASDAQ:WGS) provides deeper insights than standard genetic tests. Unlike traditional diagnostic labs, it integrates large-scale genomic databases with AI models to enhance diagnostic accuracy.

GeneDx has a strong competitive edge due to the size, breadth, and depth of its genomic database. It holds an 80% market share among genetics experts and sees a $45 billion market opportunity over the next five years.

On February 20, a Wells Fargo analyst raised the stock’s price target from $75 to $105 while maintaining an Equal Weight rating. The upward revision was based on strong Q4 earnings and 2025 revenue guidance, which exceeded consensus estimates by 5%—a target the analyst still considers conservative.